DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
This bill amends the Public Health Service Act to modify the clinical study requirements for FDA approval of biosimilar drugs. Specifically, it removes the automatic requirement that clinical studies assess immunogenicity, pharmacodynamics, or comparative clinical efficacy, instead making these assessments discretionary at the FDA's determination. The FDA may only require these assessments if it provides written justification to the applicant before the application is filed.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.